Multitarget Drug Design for Cardiovascular Disease: Bridging Chemistry and Medicine
Gyuzel Y. Mitronova, Vladimir N. Belov, Constanze Schmidt, Stephan E. Lehnart · 2026
Read Multitarget Drug Design for Cardiovascular Disease: Bridging Chemistry and Medicine by Gyuzel Y. Mitronova, Vladimir N. Belov, Constanze Schmidt, Stephan E. Lehnart (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13662224.txt.
Description
Gyuzel Y Mitronova and co-authors review drugs that hit several targets at once in a 2026 paper. Heart diseases arise from many tangled pathways, so one target drugs often fall short. A single compound that acts on several pathways could work better and cut pill counts. It could also lower dose linked side effects and slow drug resistance.
The review covers fresh advances in building such compounds for heart care. It focuses on a few compound families and how their shapes drive their effects. Links between structure and strength, safety, and healing promise are traced for each family. The authors frame the field as a bridge between chemistry craft and clinical need.
Catalog record
| CREATOR | Gyuzel Y. Mitronova, Vladimir N. Belov, Constanze Schmidt, Stephan E. Lehnart |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 73 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |